CardioGenics Holdings Ownership

CGNH Stock  USD 0.0001  0.00  0.00%   
CardioGenics Holdings holds a total of 96.05 Million outstanding shares. Almost 97.49 percent of CardioGenics Holdings outstanding shares are held by general public with 2.52 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as CardioGenics Holdings in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of CardioGenics Holdings, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CardioGenics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

CardioGenics Pink Sheet Ownership Analysis

The company recorded a loss per share of 0.01. CardioGenics Holdings had not issued any dividends in recent years. The entity had 1:10 split on the 22nd of June 2010. CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. The company was founded in 1997 and is headquartered in Mississauga, Canada. Cardiogenics Holdings operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 4 people.The quote for CardioGenics Holdings is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on CardioGenics Holdings please contact Yahia Gawad at 905-673-8501 or go to https://www.cardiogenics.com.

Currently Active Assets on Macroaxis

Other Information on Investing in CardioGenics Pink Sheet

CardioGenics Holdings financial ratios help investors to determine whether CardioGenics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CardioGenics with respect to the benefits of owning CardioGenics Holdings security.